Answers are grounded in this paper and cite their sources.
Bibliometric analysis highlights emerging trends in nanotechnology applications for triple negative breast cancer, suggesting new research directions.
Further research into ferroptosis-based therapy for TNBC, immunogenic cell death (ICD) with nano-enabled immunotherapy, multimodal nanotheranostics for TNBC, and clinical translation of NT in TNBC studies is recommended to advance nanotechnology research in TNBC.
No takes yet. Share an insight, caveat, or question.
Ogra et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: